TNXPTonix Pharmaceuticals Holding Corp.vs its industry peers
A metric-by-metric comparison of Tonix Pharmaceuticals Holding Corp. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TNXPThis | $87M#8 | — | 0.4x#1 | 6.7x#3 | 29.8%#4 | 4.6%#4 | -959.1%#5 | -55.8%#7 | -234.8%#2 | — | -72.6%#2 | — |
| NRXP | $95M#1 | — | — | 77.4x#6 | — | -13.9%#6 | -1324.4%#6 | — | — | — | — | — |
| GNLX | $94M#2 | — | 5.8x#8 | 11763.8x#11 | 0.0%#6 | -7.6%#5 | -415175.0%#11 | -199.5%#9 | -424.2%#4 | — | — | — |
| UNCY | $94M#3 | — | 1.8x#4 | 139.1x#9 | -29.0%#9 | 27.7%#3 | -4372.9%#9 | -49.8%#6 | — | — | — | — |
| PLYX | $93M#4 | — | 8.5x#9 | — | — | 70.4%#2 | — | -82.1%#8 | — | — | — | — |
| MIST | $92M#5 | — | 5.1x#7 | — | — | -51.9%#10 | — | -0.3%#2 | — | — | — | — |
| LEXX | $89M#6 | — | 18.8x#10 | 126.2x#8 | 52.0%#2 | -105.4%#11 | -1683.0%#7 | -251.2%#10 | — | — | — | — |
| EQ | $88M#7 | — | 1.6x#3 | 2.1x#2 | 13.9%#5 | -177.6%#12 | -57.5%#3 | -40.0%#4 | -368.9%#3 | — | — | — |
| RLYB | $85M#9 | 3.4x#1 | 0.9x#2 | 99.3x#7 | 34.9%#3 | 84.5%#1 | -3853.6%#8 | -9.7%#3 | — | — | — | — |
| NTHI | $85M#10 | — | — | 2120.8x#10 | -51.8%#10 | -422.3%#13 | -145637.5%#10 | — | — | — | — | — |
| EMMA | $84M#11 | — | — | 6.8x#4 | -25.2%#8 | -16.1%#7 | 1.9%#2 | — | — | 4#2 | — | — |
| COYA | $81M#12 | — | 1.9x#5 | 10.2x#5 | 123.6%#1 | -42.6%#8 | -283.9%#4 | -49.0%#5 | — | — | — | — |
| LFVN | $73M#13 | 14.7x#2 | 2.2x#6 | 0.4x#1 | -20.1%#7 | -48.3%#9 | 3.3%#1 | 15.1%#1 | 28.2%#1 | 6#1 | -25.0%#1 | 3.2%#1 |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice